Atlas Trials

Primary Central Nervous System Hodgkin Lymphoma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primary Central Nervous System Hodgkin Lymphoma

RecordFirmDate
Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma (NCT04961515)Second Affiliated Hospital, Zhejiang University, School of Medicine2021-07-01
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies (NCT01789255)National Cancer Institute (NCI)2013-06-01
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant (NCT01588015)City of Hope Medical Center2012-10-29
MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia (NCT01231919)National Cancer Institute (NCI)2011-01-01
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors (NCT01158274)National Cancer Institute (NCI)2010-06-01
Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction (NCT00499811)National Cancer Institute (NCI)2007-06-01
3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00293345)National Cancer Institute (NCI)2006-06-01
PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas (NCT00348985)National Cancer Institute (NCI)2006-03-01

Track Primary Central Nervous System Hodgkin Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.